EPISODE · Dec 19, 2025 · 24 MIN
Highlights of new treatment options for IBD from recent phase II and III trials (Abtect, Gladiator, Astro, Graviti), definitions of mild IBD
from IBD Essentials · host Axel Dignaß
Silvio Danese, Milan, internationally renowned IBD expert, former ECCO president and UEG Vice president discusses recent data from UEG 2025 on Etrasimod in mild UC (gladiator) and late breaking abstract data on obefazimod in ulcerative colitis
Embed this episode
NOW PLAYING
Highlights of new treatment options for IBD from recent phase II and III trials (Abtect, Gladiator, Astro, Graviti), definitions of mild IBD
No transcript for this episode yet
Similar Episodes
No similar episodes found.